Search

everythinglearnresearchcommunity

for

Search:↓

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

Females are more likely than males to experience long-COVID symptoms and heart issues.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Exosomes and cell culture-conditioned media improve skin quality and reduce aging signs.

The treatment might help COVID-19 related hair loss, but more research is needed.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

COVID-19 may cause a common type of hair loss called telogen effluvium.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.